Chronically increased intrarenal angiotensin II causes nephropathy in an animal model of type 2 diabetes

Frontiers in Bioscience

Volumn 11, Issue 1 P.889-1198, 2006, Pages 968-976

  Sharma, Ram ^a   Sharma, Mukut ^b   Reddy, Sreenivas ^b   Savin, Virginia J ^b   Nagaria, Abdul Mateen ^a   Wiegmann, Thomas B ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Angiotensin II; Diabetic Nephropathy; Kindey; Nephrin; Proteinuria; Slit diaphragm; Zucker Rats

Indexed keywords

ANIMALIA;

EID: 32844466545     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1853     Document Type: Article

References (48)

1. United States Renal Data System. 1999 annual data report. Am J Kid Dis 34 (Suppl 1): S1-S176, (1999)
2. Ritz E, Rychlik I, Locatelli F, Halimi S. End-stage renal failure in type II diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis 34: 795-808, (1999)
3. Ueno M, Kawashima S, Nishi S, Shimada H, Karasawa R, Suzuki Y, Maruyama Y, Arakawa M. Tubulointerstitial lesions in non-insulin dependent diabetes mellitus. Kidney Int 63 (Suppl): S191-198, (1997)
4. Schwartz MM, Lewis EJ, Leonard-Martin T, Lewis JB, Batlle D. Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy. The Collaborative Study Group. Nephrol Dial Transplant 13(10): 2547-2552, (1998)
5. Peterson RG, Shaw WN, Neel M. Zucker diabetic fatty rat as a model for non-insulin-dependent diabetes mellitus. ILAR News 32: 16-19, (1990)
6. Uehara Y, Hirawa N, Kawabata Y, Numabe A, Gomi T, Ikeda T, Omata M. Angiotensin II subtype-1 receptor antagonists improve haemodynamic and renal changes without affecting glucose metabolisms in genetic rat model of non-insulin-dependent diabetes mellitus. Am J Hypertension 12(1 Pt 1): 21-27, (1999)
7. Kennefick TM, Anderson S. Role of angiotensin II in diabetic nephropathy. Semin Nephrol 17(5): 441-447, (1997)
8. Velasquez MT, Striffler JS, Abraham AA, Michaelis OE 4TH, Scalbert E, Thibault N. Perindopril ameliorates glomerular and renal Tubulointerstitial injury in the SHR/N-corpulent rat. Hypertension 30 (5): 1232-1237, (1997)
9. Venkata C, Ram S, Fierro G. The benefits of angiotensin II receptor blockers in patients with renal insufficiency or failure. Am J Therau 2: 101-105, (1998)
10. Kedziora-Kornatowska KZ, Luciak M, Paszkowski J. Lipid peroxidation and activities of antioxidant enzymes in the diabetic kidney: effect of treatment with angiotensin convertase inhibitors. IUBMB Life 49(4): 303-307, (2000)
11. O'Donnell MP, Crary GS, Oda H, Kasiske BL, Powell JR, Keane WF. Irbesartan lowers blood pressure and ameliorates renal injury in experimental non-insulin-dependent diabetes mellitus. Kidney Int 63 (Suppl): S218-220, (1997)
12. Singh NK. Nephroprotection in diabetes mellitus. Clin Exp Hypertension 21(1-2): 85-94, (1999)
13. Duarte J, Martinez A, Bermejo A, Vera B, Gamez MJ, Cabo P, Zarzuelo A. Cardiovascular effects of captopril and enalapril in obese Zucker rats. Euro J Pharmacol 365(2-3): 225-232, (1999)
14. Fox J, Shangbo, G, Anka, AH, Navar LG. Dietary Na and ACE inhibition effects on renal tissue angiotensin I, II and ACE activity in rats. Am J Physiol 262 (31): F902-F909, (1992)
15. Mitchell KD, Jacinto SM, Mullins JJ. Proximal tubular fluid, kidney and plasma levels of angiotensin II in hypertensive ren-2 transgenic rats. Am J Physiol. 273 (Renal Physiol. 42): F246-F253, (1997)
16. Chomczynski P, Sacchi M. Simple method of RNA isolation by acid guanidium thiocynate-phenyl-chloroform extraction. Anal Biochem 162: 2156-2159, (1987)
17. Kasiske BL, Cleary MP, O'Donnell MP, Keane WF. Effects of genetic obesity on renal structure and function in the Zucker rat. J Lab Clin Med 106: 598-604, (1985)
18. Blanco S, Penin R, Class I, Lopez D, Romero R. Effects of anti-hypertensive drugs in experimental type 2 diabetes related nephropathy. Kidney Int 82 (Suppl): 27-31, (2002)
19. Richard RJ, Porter JR, Inserra F, Ferder LF, Stella I, Reisin E, Svec F. Effects of dehydroepiandro-sterone and quinapril on nephropathy in obese Zucker rats. Kidney Int 59(1): 37-43, (2001)
20. Burns KD. Angiotensin II and its receptors in the diabetic kidney. Am J Kidney Dis 36(3): 449-467, (2000)
21. Anderson S. Physiologic actions and molecular expression of the renin-angiotensin system in the diabetic rat. Min Electro Metabol 24(6): 406-411, (1998)
22. Pavenstadt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 83(1): 253-307, (2003)
23. Hoshi S, Shu Y, Yoshida F, Inagaki T, Sonoda J, Watanabe T, Nomoto K, Nagata M. Podocyte injury promotes progressive nephropathy in Zucker diabetic fatty rats. Lab Invest 82(1): 25-35, (2002)
24. Ruotsalainen V, Ljungberg P, Wartiovaara J, Lenkkeri U, Kestila M, Jalanko H, Holmberg C, Tryggvason K. Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc Nat Acad Sci 96(14): 7962-7967, (1999)
25. Wang SX, Rastaldi MP, Patari A, Ahola H, Heikkila E, Holthofer H. Patterns of nephrin and a new proteinuria-associated protein expression in human renal diseases. Kidney Int 61(1): 141-147, (2002)
26. Wong MA, Cui S, Quaggin SE. Identification and characterization of a glomerular-specific promoter from the human nephrin gene. Am J Physiol 279(6): F1027-1032, (2000)
27. Kelly DJ, Aaltonen P, Cox AJ, Rumble JR, Langham R, Panagiotopoulos S, Jerums G, Holthofer H, Gilbert RE. Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of antiproteinuric therapies. Nephrol Dial Transplant 17(7): 1327-1332, (2002)
28. Forbes JM, Bonnet F, Russo LM, Burns WC, Cao Z, Candido R, Kawachi H, Allen TJ, Cooper ME, Jerums G, Osicka TM. Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria. J Hypertension. 20(5): 985-992, (2002)
29. Aaltonen P, Luimula P, Astrom E, palmen T, Gronholm T, Palojoki E, Jaakkola I, Ahola H, Tikkanen I, Holthofer H. Changes in the expression of nephrin gene and protein in experimental diabetic nephropathy. Lab Invest 81(9): 1185-1190, (2001)
30. Langham RG, Kelly DJ, Cox AJ, Thomson NM, Holthofer H, Zaoui P, Pinel N, Cordonnier DJ, Gilbert RE. Proteinuria and the Expression of the Podocyte Slit Diaphragm Protein, Nephrin, in Diabetic Nephropathy: Effects of Angiotensin Converting Enzyme Inhibition. Diabetologia. 45(11): 1572-1576, (2002)
31. Adler S. Structure-function relationships associated with extracellular matrix alterations in diabetic glomerulopathy. J Am Soc Nephrol 5: 1165-1172, (1994)
32. Osterby R, Parving HH, Nyberg G, Jorgensen H, Lokkegaard H, Svalander C. A strong correlation between glomerular filtration rate and surface in diabetic nephropathy. Diabetologia 31: 265-270, (1988)
33. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci 90: 1814-1818, (1993)
34. Ziyadeh FN, Sharma K. Role of transforming growth factor-beta in diabetic glomerulosclerosis and renal hypertrophy. Kidney Int. 48 (Suppl): 34-36, (1995)
35. Sharma K, Jin Y, Guo J, Ziyadeh FN. Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45:522-530, (1996)
36. Mauer SM, Steffes MW, Ellis EN, Southerland DER, Brown DM, Goetz FC. Structural-functional relationships in diabetic nephropathy. J Clin Invest 74:1143-1155, (1984)
37. Steffes MW, Bilous RW, Southerland DER, Mauer M. Cell and matrix components of the glomerular mesangium in type 1diabetes. Diabetes. 41:679-684, (1992)
38. Sharma K, Ziyadeh FN. Hyperglycemic and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes. 44:1139-1146, (1995)
39. Ziyadeh FN, Sharma K, Ericksen M, Wolf G. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by activation of transforming growth factor-beta. J Clin Invest 93:536-542, (1994)
40. Shankland SJ, Scholey JW. Expression of transforming growth factor-beta 1 during diabetic renal hypertrophy. Kidney Int 46:430-442, (1994)
41. Bollineni JS, Reddy AS. Transforming growth factor-beta 1 enhances glomerular collagen synthesis in diabetic rats. Diabetes. 42:1673-1677, (1993)
42. Falk RJ, Scheinmann JI, Mauer SM, Michael AF. Polyantigenic expansion of basement membrane constituents in diabetic nephropathy. Diabetes 32: 34-39, (1983)
43. Zhu D, Kim Y, Steffes MW, Groppoli TJ, Butkowski RJ, Mauer SM. Glomerular distribution of type IV collagen in diabetes by high resolution quantitative immunochemistry. Kidney Int 45:425-433, (1994)
44. Kim Y, Kleppel M, Butkowski R, Mauer SM, Wieslander J, Michael AF. Differential expression of basement membrane collagen chains in diabetic nephropathy. Am J Pathol 138: 413-420, (1991)
45. Fukui M, Nakamura T, Ebihara I, Shirato I, Tomino Y, Koide H. ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 41:1520-1527, (1992)
46. Ihm CG, Lee GSL, Nast CC, Artishevsky A, Guillermo R, Levin PS, Glassock RJ, Adler SG. Early increased renal procollagen alpha (IV) mRNA levels in streptozotocin-induced diabetes. Kidney Int 41:768-777, (1992)
47. Magil AB. Tubulointerstitial lesions in young Zucker rats. Am J Kidney Dis 25:478-485, (1995)
48. Magil AB, Frohlich JJ. Monocytes and macrophages in focal glomerulosclerosis in Zucker rats. Nephron 59:131-138, (1991)